Showing 1 posts of 1 posts found.
The departure of high-level, big pharma executives to tiny biotechs is steadily becoming a constant stream; the latest is Bill …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO